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ABSTRACT
Mutations in Pol c represent a major cause of human
mitochondrial diseases, especially those affecting
the nervous system in adults and in children.
Recessive mutations in Pol c represent nearly half
of those reported to date, and they are nearly uni-
formly distributed along the length of the POLG1
gene (Human DNA Polymerase gamma Mutation
Database); the majority of them are linked to the
most severe form of POLG syndrome, Alpers–
Huttenlocher syndrome. In this report, we assess
the structure–function relationships for recessive
disease mutations by reviewing existing biochem-
ical data on site-directed mutagenesis of the
human, Drosophila and yeast Pol cs, and their
homologs from the family A DNA polymerase
group. We do so in the context of a molecular
model of Pol c in complex with primer–template
DNA, which we have developed based upon the
recently solved crystal structure of the apoenzyme
form. We present evidence that recessive mutations
cluster within five distinct functional modules in the
catalytic core of Pol c. Our results suggest that
cluster prediction can be used as a diagnosis-
supporting tool to evaluate the pathogenic role of
new Pol c variants.
INTRODUCTION
Mitochondrial DNA polymerase, Pol g, is the sole known
DNA polymerase in animal mitochondria and is respon-
sible for mitochondrial DNA (mtDNA) replication and
repair (1,2). The human enzyme is a heterotrimer consisting
of a catalytic subunit, Pol gA, and dimer of an accessory
subunit, Pol gB (3). Pol gA is a member of the family A
DNA polymerase group to which bacterial DNA Pol I
belongs (1). It comprises three domains: an N-terminal
domain containing 30!50 exonuclease (exo) activity, a
spacer domain and a C-terminal domain, containing
50!30 DNA polymerase (pol) activity in three subdomains
termed the palm, ﬁngers and thumb. Pol gA also bears a
50-deoxyribose phosphate lyase activity (4), but the location
of its active site is unknown. The accessory subunit, Pol gB,
serves as a processivity factor, enhancing the DNA-binding
afﬁnity and catalytic activities of Pol gA (5,6). The crystal
structure of human Pol g in its apoenzyme form was solved
recently (PDB code 3IKM) (7).
Mutations in Pol g represent a major cause of human
mitochondrial diseases, especially those affecting the
nervous system in adults and in children. Dominant mu-
tations typically cause adult-onset myopathies and
encephalopathies (8,9), whereas recessive mutations
result in severe adult or juvenile onset ataxia-epilepsy syn-
dromes (MIRAS, SCA-E, SANDO) (10–12), or
devastating early-childhood Alpers syndrome (Alpers–
Huttenlocher syndrome) characterized by intractable
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epilepsy, psychomotor retardation and liver failure that
leads to early death (13,14). On the molecular level,
POLG syndromes are accompanied by either
tissue-speciﬁc mtDNA depletion, deletions or combin-
ation of both (15,16). To date, more than 145 POLG1
disease mutations have been identiﬁed (Human DNA
Polymerase gamma Mutation Database, http://tools
.niehs.nih.gov/polg/), of which more than half are reces-
sive. The functional consequences of dominant mutations,
which affect primarily catalytic residues in the pol domain,
have been explained by effective competition for the DNA
substrate by the mutant Pol g with the wild-type enzyme
(7,17,18), and by site-speciﬁc stalling of mutant DNA
polymerase (18). Studies that explain effects of individual
recessive mutations on protein function are limited (19–
22). The majority of the reported recessive mutations are
linked to the most severe form of POLG syndrome,
Alpers–Huttenlocher syndrome. Manifestation of Alpers
disease typically requires the presence of at least two re-
cessive, compound heterozygous mutations, and is
accompanied primarily with mtDNA depletion (16,23).
The detailed mechanisms of pathogenesis and mtDNA
depletion are unknown.
The assignment of a newly identiﬁed amino acid substi-
tution as a pathogenic mutation is generally based on the
absence of the variant in the normal population, conser-
vation of the site among species and segregation in
families. These assignments are particularly challenging
because of the extensive variation in the amino acid se-
quences of Pol gA in the normal population. To date, data
accumulated on recessive disease mutations show that
they are almost uniformly distributed among the three
structural domains of the catalytic subunit and in most
cases, it is unclear which property of the enzyme is
affected, and how it contributes to mtDNA deletion or
depletion.
The present study aims to assess the structure–function
relationships for recessive disease mutations, by reviewing
existing biochemical data on site-directed mutagenesis of
the human, Drosophila and yeast Pol gs, and their
homologs from the family A DNA polymerase group;
we do so in the context of the recently solved crystal struc-
ture of human Pol g (7), onto which we have modeled
primer–template DNA (ptDNA). We present evidence
that recessive mutations cluster within ﬁve distinct func-
tional modules in the catalytic core of Pol g that we des-
ignate as ‘Alpers Clusters 1–5’. We note that our analysis
of the recessive mutations found in compound heterozy-
gous form in Alpers patients reveals that a severe disease
manifestation is typically caused by a combination of at
least two mutations from different clusters. Our results
suggest that cluster prediction can be used as a
diagnosis-supporting tool to evaluate the pathogenic role
of new Pol g variants.
APPROACH TO COMPARATIVE STRUCTURAL
ANALYSIS
We docked ptDNA into the putative DNA-binding
channel of the apoenzyme form of the human Pol g
structure (PDB code 3IKM) (7) by superposition of the
closed ternary complex of T7 Pol bound to ptDNA and
dNTP (PDB code 1T8E) (24). The coordinates of the re-
sulting Pol g: DNA model are provided in Supplementary
Data. To ensure reliable positioning for subsequent struc-
tural analysis of Alpers recessive mutations, we evaluated
three different alignments of the Pol g and T7 palm
domains that are presented in Supplementary Figure S1.
First, we aligned the palm domain of Pol gA (PDB code
3IKM, chain A, residues 815–910 and 1095–1239) with
that of T7 Pol (PDB code 1T8E, chain A, residues 409–
487 and 611–704). Additionally, we aligned the two struc-
tures by superposition of their 12b-loop-13b motifs
from the palm subdomain, encompassing residues
G1127-E1144 in Pol gA and F646-E663 in the T7 catalytic
core [for secondary structure element assignment see (25)].
This part of the central b-sheet in the palm subdomain is
the most structurally conserved element between DNA
polymerases in the family A DNA polymerase group
(25), and it superposed with an RMSD of 1.906 A˚ for
Pol gA and T7. Alignment showed that the functionally
signiﬁcant secondary structure elements (SSEs) of the pol
domain of Pol gA, including helixes aO, aL and aQ, as
well as the loop corresponding to the 7b-loop-8b motif in
T7 Pol, are tilted away from the active site, as compared
to the analogous SSEs from T7 Pol and Klenow.
This suggests conformational rearrangements in the Pol
g catalytic core upon DNA binding. To model the
ptDNA in the putative DNA-binding channel of Pol gA,
and to identify residues that interact with the DNA
duplex, we performed a comparative analysis of the T7
Pol (24) and Klentaq (26) DNA complexes in both the
open and closed states. We sought to identify SSEs in
the pol domain that fulﬁll the requirements of interaction
with DNA and preservation of conserved positions
between the enzymes. As a result, the Q-helix and the
7b-loop-8b motif were identiﬁed, and a third alignment
of Pol gA and T7 Pol was based on superposition of
their aQ helices (residues M1093-E1122 in Pol g and
P606-E635 in T7 Pol), and the hairpins formed by the
7b-loop-8b (residues T846-V855 in Pol g and P422-T431
in T7 Pol). The RMSD for the superposed hairpins was
1.397 A˚.
CLUSTERING OF ALPERS DISEASE MUTATIONS
WITHIN THE CATALYTIC CORE OF POL c
Recessive mutations are distributed along the length of
the POLG1 gene sequence (http://tools.niehs.nih.gov/
polg/), but they cluster within the tertiary structure
of Pol gA to distinct regions within the catalytic
core (Figure 1). Five functional modules, termed clusters
1–5, were assigned within Pol gA as follows: Cluster 1
(in green) locates within the pol domain and comprises
largely residues affecting DNA polymerase activity;
Cluster 2 (in yellow) represents residues lining the
upstream DNA-binding channel; Cluster 3 (in red) is
associated with a novel structural motif in the ﬁngers
subdomain, which we propose confers partitioning
of the DNA substrate between the pol and exo
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sites; Cluster 4 (in blue) lies on the periphery of the exo
domain and mediates interactions with the distal Pol gB,
stabilizing the Pol g:DNA complex; and Cluster 5 (in
cyan) locates within the spacer domain and represents a
region that we propose is involved in replisome
interactions.
ALPERS CLUSTER 1: RESIDUES AFFECTING 50-30
DNA POLYMERASE ACTIVITY
Catalysis of template-directed nucleotide polymerization
in DNA polymerases proceeds via a phosphoryl transfer
reaction assisted by two Mg2+ ions (27,28). Incorporation
of the correct dNMP is mediated by a nucleotide-induced
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Figure 1. Alpers disease mutations cluster within functional modules in the catalytic subunit of Pol g. Upper panel: schematic diagram of the
POLG1 gene showing the distribution of recessive Alpers disease mutations (Human DNA Polymerase gamma Database, http://tools.niehs.nih.gov/
polg/). AID and IP in the spacer domain refer to the accessory (subunit) interacting and intrinsic processivity subdomains, respectively, that are
discussed in the text; NTD refers to the N-terminal domain. Lower panel: tertiary structural representation of the apoenzyme form of Pol g [PDB
code 3IKM, (7)] with modeled DNA, identifying the positions of ﬁve functional modules (shown in mesh) that are deﬁned by clusters of amino acid
residues (shown as spheres) affected by Alpers disease mutations as follows: Cluster 1, green; Cluster 2, yellow; Cluster 3, red; Cluster 4, blue; Cluster
5, cyan. The domains of Pol gA are shown as surface representations, and in part as secondary structural elements (SSEs) that are colored as
depicted in A. The proximal and distal accessory subunits are shown as surface representations in light and dark gray, respectively. Primer–template
DNA was docked as described in the text and is displayed as orange ribbons.
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conformational shift of the ﬁngers subdomain between an
open and closed state; the closed state results in phos-
phoryl transfer when correct Watson–Crick base pairs
between the incoming nucleotide and a templating base
can ﬁt stably in the active site (29,30). Similarities in the
overall mechanism of DNA polymerases suggest a
conserved structure of their active sites and provide a
basis for comparative structural analysis and extrapola-
tion of site-directed mutagenesis data from one DNA
polymerase to its close homologs. The amino acid
residues that we attribute to Alpers Cluster 1 contribute
to nucleotide polymerization per se, to shaping the overall
architecture of the pol active site, or to positioning the
primer template within the active site (Figure 2A).
Catalytic residues
The largest group of recessive Alpers mutations map to
the pol domain in POLG1 (Figure 1), and a number of the
affected amino acids are likely involved in catalysis by
Pol g. Residues E1136 and K1191 surround the highly
conserved residues D890 and D1135 (Figure 2B), which
locate at the base of the pol active site and have been
shown to coordinate the two magnesium ions required
for catalysis (7). In vitro mutagenesis of residue E883 in
Klenow (E1136 in Pol g) resulted in decreased pol rate,
kcat and afﬁnity for dNTPs and DNA (31,32), which ﬁts
with the recessive nature of this mutation and its effect on
mtDNA copy number in vivo (16,23). Comparative struc-
tural analysis of Pol g and its close homologs revealed that
E895 likely confers discrimination against ribonucleotides,
and it is involved in aligning the incoming dNTP within
the catalytic site, together with the catalytic residues Y955
and Y951 [Figure 2C (33)]. Interestingly, E895 also
occupies part of the dNTP-binding pocket, and whereas
E895G is a recessive mutation, Y955C is dominant.
In vitro mutagenesis of Pol g showed that the Y955C
variant exhibited dramatically reduced catalytic activity,
but had the same afﬁnity for DNA as the wild-type
enzyme (33). In a disease situation, these effects cannot
be compensated for by the wild-type allele and as a
result, Y955C causes a dominantly inherited adult-onset
mitochondrial myopathy (autosomal dominant progres-
sive external ophthalmoplegia) associated with mtDNA
deletions (34). E1136 is part of one of three conserved
sequence motifs in the palm subdomain of family A
DNA polymerases (the PolC motif, Figure 2B). Its coun-
terparts E655 in the T7 Pol (25) (Figure 2B) and E786 in
the Klentaq (26) structures are not in contact with primer
or incoming dNTP, but mutagenesis of Klenow showed
that this residue is critical for catalysis (31). The ternary
complex of T7 Pol reveals an electrostatic interaction
between E655 and H704, and suggests that the role of
E655 is to position H704 in close proximity to the phos-
phate moiety of the 30 nt in the primer strand, and it was
shown to be essential for catalysis (25). K1191 of Pol g
occupies the equivalent position of H704 in T7 Pol, sug-
gesting that it would interact with E1136 in a similar
manner upon binding of the primer template to facilitate
catalysis.
In contrast to the rigid pocket formed by the palm
active site residues, the opposite half of the active site is
highly ﬂexible to allow a fast transition between open and
closed conformations of the ﬁngers subdomain. This con-
formational asymmetry provides the structural basis for
the high afﬁnity of DNA polymerases for the primer–
template junction: the template must be bound ﬁrmly
and consistently each catalytic cycle to assure the ﬁngers
sufﬁcient freedom to examine each incoming nucleotide.
Several Alpers mutations have been reported in this region
of the ﬁngers, scattered mainly along the O-helix
(Figure 2C). Biochemical studies on the A957S mutant
showed mild defects in kcat and dNTP binding, but a
modest increase in DNA-binding afﬁnity (33). A957
locates in the loop between helices O and O1, within one
of the three hinge regions, the ‘GAG’ hinge (residues
G956/A957/G958), which in related DNA polymerases is
known to confer the ﬂexibility necessary for closing and
opening of helixes O and O1 (27,35). Glycine to alanine
substitution in the GAG hinge in T7 Pol resulted in
complete loss of catalytic activity, which can be attributed
to complete or diminished ability to shift between the open
and closed states (36). Mutations affecting the hinge
region likely introduce steric clashes that would limit the
extent of conformational shifts. Interestingly, different
amino acid replacements for A957 in Pol g do not have
similar consequences: A957S causes dominantly inherited
adult-onset myopathy with multiple mtDNA deletions,
whereas an A957P substitution has been reported only
as a recessive, compound heterozygous mutation in
patients with Alpers syndrome and mtDNA depletion.
A957S showed an increased afﬁnity for DNA (33), a con-
sequence that is consistent with a slower open–close rate,
and could potentially cause pol stalling or dissociation. In
contrast, the severe defect caused by A957P suggests that
the presence of proline in the hinge abolishes the ﬂexibility
between helixes O and O1, a defect that we predict will
result in decreased afﬁnity for both dNTP and DNA and
may prohibit the formation of a productive ternary
complex. The loop between helixes O and O1 has been
shown to form the pre-insertion site in Geobacillus
stearothermophilus Klenow to accommodate the ssDNA
template and prevent its premature entry into the active
site (35). However, the available library of DNA polymer-
ase structures reveals variability in the pre-insertion site,
making it difﬁcult to assign a critical role. Residue K947,
which is associated with Alpers syndrome, is located on
the O-helix adjacent to R943. The corresponding residues
in T7 Pol (K522 and R518, respectively) contact the tri-
phosphate moiety of the incoming nucleotide in the closed
ternary complex (PDB code 1T8E). These electrostatic
interactions provide most of the driving force for
O-helix movement, and mutations in these positions will
weaken interactions.
Architectural residues
Optimal catalysis requires not only the residues interacting
directly with dNTP and primer template, but also those
that maintain the architecture of the pol active site.
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We suggest that the pathogenic role of the Alpers muta-
tions Q879H, T885S, L886P, G888S, E1143 and D1184N
can be attributed to modiﬁcations in the local b-sheet
architecture surrounding the catalytic residues in the
palm (Figure 2A, upper panel). Defects are predicted to
reduce pol rate, and it appears that the closer the mutated
architectural residue is to the catalytic site, the more
pronounced its effect. In support of this, in vitro muta-
genesis of Q879 and T885, located a distance of 15 A˚
from the catalytic residues, caused only a 2-fold decrease
in pol rate (20). In contrast, mutagenesis of E883
located at the beginning of the strand b13 within the
catalytic site in Klenow (E1136 in Pol gA) reduced kcat
26-fold (31).
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Figure 2. Alpers Cluster 1 mutations affect the 50–30 DNA polymerase activity of Pol g. Amino acid residues affected by Alpers Cluster 1 mutations
in POLG1 are shown as green spheres. Other Pol g residues that are discussed in the text are shown in brown, and T7 residues are shown in red. Pol
domain SSEs are shown in pink according to the schematic shown in Figure 1; ptDNA is indicated by orange (template) and brown (primer) strands.
The incoming dNTP is shown in blue. Mg2+ ions are shown as small gray spheres. A, upper panel, overview of the positions of Alpers Cluster 1
mutations with dashed black lines indicating the regions described in the text and depicted in B–D; A, lower panel, overview of the positions of
Alpers Cluster 1 mutations relative to ptDNA and incoming dNTP; B–D, positioning of Pol g residues in the apoenzyme form [PDB code 3IKM (7)]
and T7 Pol residues in its closed ternary complex [PDB code 1T8E (25)] relative to ptDNA and incoming dNTP, with the dashed arrow showing the
expected movements of the Pol g residues upon formation of a closed complex: B, Alpers mutations surrounding the Mg2+-binding residues; C,
Alpers mutations affecting O-helix movement and dNTP binding, with the T7 Pol O-helix in its closed conformation superimposed in red; D, Alpers
mutations affecting the RR loop and the surrounding residues.
9076 Nucleic Acids Research, 2011, Vol. 39, No. 21
 at H
elsinki U
niversity Library on M
ay 18, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
The Alpers mutation D930N (Figure 2C) was studied
in vivo in yeast, and led to complete loss of mtDNA (37).
The corresponding residue in T7 Pol (D504) interacts with
triphosphate-binding residue R518 (R943 in Pol g) in the
closed conformation (PDB code 1T8E), and therefore con-
tributes indirectly to correct dNTP binding. Residues
T914 and L966 located in the ﬁngers subdomain
(Figure 2C) are conserved only among Pol gs, and are
linked to Alpers syndrome. Our structural analysis
predicts that mutations in these residues will likely com-
promise the stability and conformation, and/ or the tran-
sition rate between the open and closed states of the
ﬁngers. In sum, we propose that the primary effect of mu-
tations surrounding the O-helix residues is altered afﬁnity
for dNTPs, which decreases pol rate.
Residues conferring a high afﬁnity of the pol site for the
primer–template junction
Docking of DNA onto the Pol g structure shows that the
DNA-binding channel of the enzyme encompasses 20 bp
of DNA duplex, whereas those in T7 Pol and Klentaq are
relatively short and interact with 8 bp of DNA duplex
(24–26). In Pol g, similar to other family A DNA poly-
merases, the DNA-binding channel starts with residues
located in the b7-loop-b8 motif in the palm, which form
extensive contacts with the ﬁrst four base pairs in the
ptDNA. In Pol gA, this fragment encompasses residues
842–856 and appears as a loop in the crystal structure
with the current resolution of 3.24 A˚ (7). Because the
b7-loop-b8 motif has two arginines in its tip, R852 and
R853, the former of which is conserved only among Pol
gs, we designated it as the ‘RR loop’ (Figure 2D). Several
recessive mutations affect the RR loop: G848S, T849H,
T851A, R852C and R853Q, as well as the surrounding
residues H1134R and H1110Y. In vitro mutagenesis of
G848, T851, R852 and R853 in human Pol g (20), and
R668 in Klenow ((31,32), corresponding to R853 in Pol
g), caused a dramatic decrease in catalytic activity and
DNA-binding afﬁnity. Polesky et al. (32) highlighted the
complex effect of these mutations, noting that a speciﬁc
amino acid can bind a critical part of the substrate,
contributing to the overall afﬁnity of the enzyme for
ptDNA, and to catalysis by positioning the substrate in
the active site. Comparative structural analysis of Pol g
homologs solved in ternary complexes with bound DNA
prompts us to propose that the primary function of the
RR loop is in binding and alignment of ptDNA within the
DNA-binding channel. H1134 locates adjacent to the RR
loop in the tertiary structure (Figure 2D). The correspond-
ing histidines in Klenow (31,32), T7 Pol (25) and Klentaq
(26) were shown to be essential for DNA binding, and for
coordination of the ﬁrst nucleotide in the primer strand.
Analysis of Pol g suggests that Q1102 from the Q-helix
(Q615 in T7 Pol) and R853 (R429 in T7 Pol) from the RR
loop coordinate the ﬁrst base pair in the ptDNA, and
therefore may be crucial in sensing a mispair. T851
(T427 in T7 Pol) likely participates indirectly by position-
ing Q1102. T849 is predicted to coordinate the DNA
duplex by interaction with the phosphate moiety of the
third nucleotide from the 30-end of the primer. In the
Pol g apoenzyme structure, the side chains of the
residues from the RR loop are oriented differently than
the orthologous residues in the T7 Pol ternary complex,
which suggests that DNA and dNTP binding affect the
positions of the residues that coordinate them. For
example, R853 in the Pol g apoenzyme interacts with the
metal-binding residue D1135 as was noted by Stumpf and
Copeland (17) and with E895, but in complex with DNA,
R853 would shift to interact with the base of the 30 nt of
the primer strand, as in T7 Pol (24–26). A distinguishing
feature of the RR loop, in comparison with the
orthologous b7-loop-b8 motif in other family A DNA
polymerase group members, is the electrostatic interaction
between R852 and D1107, which may confer additional
stability to the RR loop in Pol g (Figure 2D). Disease
mutations in this domain affect primarily DNA binding
and positioning in the active site channel, manifesting
defects in both DNA-binding afﬁnity and in catalytic
efﬁciency.
CLUSTER 2: RECESSIVE MUTATIONS AFFECTING
THE UPSTREAM DNA-BINDING CHANNEL
Processivity of a DNA polymerase depends both on
DNA-binding afﬁnity and on the rate of DNA polymer-
ization. Structural analysis shows that the mutations af-
fecting interaction of Pol g with the upstream DNA
duplex are located within the spacer domain (Figure 1).
This would argue that the AID [accessory (subunit)-
interacting domain] and IP (intrinsic processivity)
subdomains adopt a different conformation in Pol g:
DNA complexes. To evaluate the potential impact of re-
cessive spacer region mutations on DNA binding, we con-
sidered results of in vitro mutagenesis of spacer domain in
Drosophila Pol g (38) and in Saccharomyces cerevisiae
Mip1 (22) (Figure 3). Analysis of the Pol g structure
with modeled ptDNA reveals that residues K755 from
the IP subdomain and Q497 in the K-tract of the AID
subdomain interact with upstream DNA. In the human
Pol g:DNA model, the L752P and A767D substitutions
would affect the structure in the tip of IP subdomain,
which contacts the minor groove of the DNA duplex in
a similar way as reported for T7 Pol [residues T354-V363
(25)]. In the Pol g:DNA complex, L752 and A767
neighbor the K768/D769/F770 triplet from ﬂy Pol g;
triple alanine substitution of KDF in ﬂy Pol g resulted
in a 1.4-fold decrease in DNA-binding afﬁnity (38). We
predict that the Alpers A767D mutation likely causes
similar consequences for DNA binding. Mutations of
P587 and P589 in the spacer domain are also linked to
Alpers disease. These residues constrain the b–hairpin
loop between the IP and AID subdomains and are pos-
itioned close to the Y452/E453/E454 triplet that lies within
the thumb [corresponding to the YED triplet in
Drosophila Pol g (38)]. We postulate that the P587L and
P589L mutations may suffer the same consequences as for
the triple alanine substitution of YED in the ﬂy enzyme,
which caused reduced processivity, most likely as a result
of misalignment of the ptDNA, with respect to the pol
catalytic site (38). Furthermore, a triple alanine mutant
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of P556A/K557A/L558A in the ﬂy was shown to be com-
pletely deﬁcient in DNA binding and pol activity (38); this
defect is likely due to disruption of the hydrophobic struc-
ture of the spacer domain, which shapes the DNA-binding
channel wall. Notably, the residue affected in the common
A467T human disease allele is also part of this PKL
hydrophobic center, and its biochemical properties most
likely derive from similar structural alterations that inter-
rupt hydrophobicity with the introduction of a hydroxyl
group. Whereas we and others have found that the A467T
catalytic core alone exhibits highly reduced DNA-binding
afﬁnity and pol activity (19,21), we showed that these
defects are mitigated partially by its association with the
accessory subunit (21). This likely results from partial sta-
bilization of the overall conformation of mutant catalytic
core within the reconstituted Pol g holoenzyme.
CLUSTER 3: MUTATIONS ASSOCIATED WITH A
NOVEL, POL c-SPECIFIC FUNCTIONAL MODULE,
CONFERRING PARTITIONING OF DNA
SUBSTRATE BETWEEN THE POL AND
EXO ACTIVE SITES
Comparative analysis of the pol domains from human Pol
g, T7 Pol and T7 RNA Pol reveals a remarkable structural
similarity in their overall folds. In fact, the only signiﬁcant
difference between the analogous pol domains lies in the
region that connects the P-helix of the ﬁngers subdomain
and Q-helix of the palm (Supplementary Figure S2), which
contains a novel module (Figure 4) whose amino acid
sequence is highly conserved in Pol gs from yeast to
man. This, and the ﬁnding that several recessive Alpers
mutations cluster in this region (Figure 1), argue that it
serves an important role. Indeed, in our Pol g:DNA
model, this module extends into the DNA-binding
channel in a position very near the pol active site (<10 A˚
from the Mg2+-binding catalytic residues). In bacterio-
phage N4 RNA polymerase (PDB code 2PO4) (39) and
in T7 RNA polymerase [PDB code 1ARO (40);
Supplementary Figure S2], the fragment connecting the
ﬁngers with the helix corresponding to the Q-helix in Pol
g participates in speciﬁc recognition of the transcriptional
promoter; it is aptly termed a speciﬁcity loop (39–41). In
Pol g, we have adopted the term ‘partitioning loop’ based
upon the functional role we propose it serves. We discuss
our rationale below, and use it to establish structure–
function justiﬁcations of disease manifestation for the
Alpers mutations we assign to Cluster 3.
We propose that the partitioning loop modulates the
partitioning of the primer strand between the pol and
exo active sites by forming stable contacts with correctly
Exo active site
SYW
Pol active site
P1073
Partitioning
Loop
R1047
S305
L304
Orienter
R309
G303
Exo active site
SYW
Pol active site
P1073
Partitioning
Loop
R1047
S305
L304
Orienter
R309
G303
B
A
Figure 4. Alpers Cluster 3 mutations are associated with a novel Pol
g-speciﬁc functional module proposed to be involved in primer strand
partitioning between the pol and exo sites. Amino acid residues affected
by Alpers Cluster 3 mutations in POLG1 are shown as red spheres/
mesh adjacent to a novel alpha helix with an associated loop–hairpin
(the partitioning loop), also shown in red. The brown spheres and mesh
represent the SYW (ﬂy)/ SFW (human) and surrounding residues, re-
spectively, that are described in the text. The pol domain is shown as a
surface representation in pink and the exo domain is shown in purple,
according to the schematic shown in Figure 1; ptDNA is indicated by
orange (template) and brown (primer) strands. (A) The predicted
position of the partitioning loop relative to ptDNA in the pol mode,
and (B) represents the exo mode. To dock the frayed ptDNA in the exo
active site, the exo domain residues 324–518 of Klenow (PDB code
1KLN) were aligned with the exo domain residues 170–440 of Pol g
(PDB code 3IKM) (Supplementary Figure S3).
K561
A467
YED
Q497
G517
R722
PKL
L605
K755
L752
A767
KDF
P587
P589
Figure 3. Alpers Cluster 2 mutations affect the upstream DNA-binding
channel of Pol g. Amino acid residues affected by Alpers Cluster 2
mutations in POLG1 are shown as yellow spheres. Other Pol g
residues that are discussed in the text are shown in brown. Spacer
domain SSEs are shown in magenta and pol domain SSEs are in
pink according to the schematic shown in Figure 1; ptDNA is indicated
by orange (template) and brown (primer) strands. The spacer domain is
also shown as a transparent surface representation in pale gray and the
exo domain is shown in purple.
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base-paired ptDNA, and destabilizing ptDNA that
contains mispairs or lesions. Comprising residues 1050–
1095, the atomic structure reveals that the ﬁrst 10
residues of the partitioning loop adopt an a-helical fold
that extends from the ﬁngers subdomain directly into the
DNA-binding channel. The beginning of this helix
contains a W1049XGG1052 motif, which is strictly
conserved in Pol g, and a similar motif is also present in
T7 Pol (W579XAG582). Our Pol g:DNA model shows that
the WXXG motif maps to the same region of the ﬁngers
domain in both Pols. In T7 Pol, it is responsible for
binding downstream template ssDNA via base-stacking
interactions between W579 and the nucleotide base
[PDB code 1T8E (25)], and likely performs an equivalent
function in Pol g. The novel functionality that the parti-
tioning loop contributes to Pol g is achieved by its unusual
loop–hairpin component spanning residues 1060–1074
that appears to grip the modeled ptDNA along the
major groove as shown in Figure 4A. We propose that it
uses a steric exclusion mechanism that confers exquisite
speciﬁcity by associating closely with the major groove of
primer template, such that correctly base-paired substrates
are bound stably. In contrast, DNA lesions and mispairs
that adopt an altered helical structure clash sterically with
the partitioning loop, resulting in exclusion of the primer
template from the pol active site. Excluding primer
template may facilitate fraying of the duplex, generating
ssDNA primer ends that can be bound by and hydrolyzed
in the exo active site (Figure 4B).
Mutations in the residues composing the partitioning
loop, such as the Alpers mutations R1047W and
P1073L, as well as the progressive external ophthalmople-
gia mutations G1051R and G1076V, have been studied
in vivo. Yeast strains homozygous for G1051R Pol g ex-
hibited a point mutational frequency >10-fold higher than
the wild-type strain, and heterozygous strains showed
frequencies >2-fold higher relative to homozygous
wild-type strains (42). Increased point mutation
frequencies were also reported for yeast strains heterozy-
gous and homozygous for the Alpers mutation P1073L
and the G1076V mutation associated with progressive
external ophthalmoplegia (22,43). Both the P1073L and
G1076V mutations cause substitutions in strictly
conserved residues located in the loop region that is
expected to contact DNA, and the G1051R mutation
affects a strictly conserved glycine in the WXXG motif.
Interestingly, yeast strains heterozygous and homozygous
for L304R, S305R, Q308H, R309L and R309H showed
similar increases in point mutation frequency as well as
mtDNA depletion (43). These exo domain residues are
located in a loop–helix motif adjacent to the partitioning
loop, and have been described previously as the orienter
module (22) (Figure 4). When S305R and P1073L were
present as compound heterozygous, the point mutation
frequency increased drastically to >70-fold that of the
wild-type strain (44). Non-complementation of these two
mutations suggests that both are involved in the same
function, and we propose that the role of the orienter
module is to position correctly the partitioning loop.
L304R, R309H, R309L and W312R were analyzed bio-
chemically by producing and purifying homologous yeast
Pol g variants (22). All variants exhibited reduced
DNA-binding afﬁnity and reduced pol activity and in
addition, the L304R variant showed a signiﬁcant
increase in exo activity (22). An identical biochemical
phenotype was reported previously in the ﬂy Pol g SYW
triple alanine variant, which correspond to thumb residues
S799/F800/W801 in human Pol g (38). As illustrated in
Figure 4, the SYW residues are located on the face of
the thumb subdomain directly across the DNA-binding
channel from the orienter module, and we predict that
this region of the thumb plays an equivalent role to the
orienter module. Therefore, we deﬁne Cluster 3 as muta-
tions affecting residues of the partitioning loop, as well as
nearby residues that govern the position and conform-
ation of the partitioning loop. Mutations in Cluster 3
will alter the balance between pol and exo activity and
diminish the ﬁdelity of the polymerase. We note the pos-
sibility that enhanced ﬁdelity may also be experimentally
feasible, introducing the potential to engineer a ﬁne-tuned
anti-mutator replicase.
In sum, our justiﬁcation for the proposed role of the
partitioning loop is based on its sequence conservation
among Pol g’s from yeast to man, its positioning relative
to the speciﬁcity loop found in T7 RNA Pol, the clustering
of several recessive Alpers mutations in this region, its
absence in any other Pol family and the documented
high ﬁdelity of Pol g. We argue that an alternate hypoth-
esis that this structural element would simply rotate away
upon DNA binding (7) seems unlikely based on the above
considerations and, in particular, on the evolutionary con-
servation of a novel structural module that is positioned
strategically in the DNA-binding channel very near the
pol active site. Clearly, validation of either hypothesis
warrants future experimentation.
CLUSTER 4: MUTATIONS AFFECTING POL cA
INTERACTIONS WITH THE DISTAL POL cB UPON
DNA BINDING BY POL c HOLOENZYME
Pol gA contains independent 50–30 DNA polymerase and
30–50 exonuclease active sites whose functions are
coordinated in proofreading DNA synthesis. The human
Pol g crystal structure showed that its homodimeric Pol gB
interacts asymmetrically with Pol gA, such that one Pol gB
protomer forms the dominant subunit interface and is
designated as the proximal accessory subunit, while the
other protomer makes very limited contact with Pol gA
and is designated as the distal accessory subunit (7). In
fact in the apoezyme structure, the Pol gA interaction
with the distal Pol gB is mediated through one ion bond
between Pol gA R232 and Pol gB E394 [(7) and Figure 5].
A subsequent biochemical study on the interaction
between the catalytic and accessory subunits showed
that the proximal Pol gB increases DNA-binding afﬁnity
of the holoenzyme, while the distal protomer enhances the
polymerization rate of the holoenzyme (45). Again as sug-
gested in the section on Cluster 2, we posit that the holo-
enzyme likely undergoes substantial conformational
rearrangements in the IP and AID subdomains of the
spacer upon formation of an active complex with DNA.
Nucleic Acids Research, 2011, Vol. 39, No. 21 9079
 at H
elsinki U
niversity Library on M
ay 18, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Mapping of Alpers mutations within the crystal struc-
ture revealed that the majority of the mutations in the exo
domain cluster on the protein surface within 13–17 A˚ from
Pol gA residue R232 (Cluster 4 shown in blue in Figures 1
and 5). The functional role of this region can be deduced
from biochemical studies on mutations of the neighboring
R232 (46) and L244 residues (22,43). Mutations of R232
were shown to decrease pol activity, DNA-binding afﬁnity
and processivity of the holoenzyme yet at the same time,
to enhance its exonuclease activity, which was also
rendered less selective for mismatches (46). These data
argue that in the Pol g:DNA complex, and/or in its
ternary complex with dNTP, the distal accessory subunit
associates more tightly with the catalytic subunit, thereby
enhancing binding of the upstream DNA in the pol mode,
and limiting the rate of translocation of the frayed 30-end
of the primer to the exo site (46). Accordingly, an
orthologous variant of the L244P human mutation in
yeast caused increased mutation frequency (22,43).
Previous site-directed mutagenesis of human Pol gB also
suggested extensive interaction between the catalytic and
distal accessory subunits within the ternary complex (5).
Analysis of the Pol g apoenzyme structure shows that
E445 and T447 of Pol gB are located at the tip of the its
C-terminal region, and that only in the distal subunit are
these residues oriented toward Cluster 4 on the edge of exo
domain. A double mutation of these residues (E445A/
T447A) led to a dramatic decrease of the stimulatory
effect of Pol gB on the wild-type Pol gA, and a decrease
in DNA binding (5). We propose that residues in Cluster 4
of Pol gA contribute to tight interaction between exo
domain of catalytic subunit and the distal accessory
subunit, resulting in more extensive enclosure of the
primer template in the pol mode. We also predict the par-
ticipation of the AID of the spacer domain in these con-
formational changes, because it is associated intimately
with the accessory subunit. In support of this, biochemical
studies performed on the yeast Pol g core variant of Alpers
mutation R574, which is located in the AID subdomain,
showed not only reduced DNA-binding afﬁnity, but also
reduced exo activity and a severe processivity defect
(22,43). To some extent, these interactions would
provide structural constraints on the upstream DNA in
the direction toward the partitioning loop. Therefore,
the partitioning loop, orienter module and thumb in Pol
gA, and the interface between its exo domain and the
distal accessory subunit might function in a concerted
manner to affect switching between the pol and exo
modes in Pol g function.
CLUSTER 5: MUTATIONS AFFECTING A REGION
OF THE IP SUBDOMAIN THAT IS LIKELY
INVOLVED IN REPLISOME CONTACTS
Many reported Alpers mutations (L623W, R627W/Q,
P648R, G737R, G746S, W748S and F749S) map to the
distal surface of the IP subdomain (Figure 6). We con-
sidered these as distinct from the Cluster 2 residues
because they are located much further from the
DNA-binding channel. In addition, in vitro studies of
W748S and R627W/Q variants showed no defects in pol
activity, processivity or DNA-binding afﬁnity (47,48). In
contrast, biochemical defects were demonstrated earlier in
R574
C224
R227
T251 L244 R232E394
E445
T447
AID
Figure 5. Alpers Cluster 4 mutations affect Pol gA interactions with
the distal Pol gB upon DNA binding by Pol g holoenzyme. Amino acid
residues affected by Alpers Cluster 4 mutations in POLG1 are shown as
blue spheres/ mesh and are located largely within the exo domain
(shown in purple). The helix shown in magenta is the AID (accessory
interacting domain) of the spacer region that interacts with the
proximal accessory subunit. Other domains are colored according to
the schematic shown in Figure 1; duplex DNA is indicated by the
orange strand. Orange spheres indicate the positions of the accessory
subunit residues described in the text. The proximal and distal acces-
sory subunits are shown as surface representations in light and dark
gray, respectively.
W620
F749
G737
W748Y622
L623
R627
G746
E641 (tam )
P648
G619
9
Figure 6. Alpers Cluster 5 mutations are proposed to affect replisome
interactions. Amino acid residues affected by Alpers Cluster 5 muta-
tions in POLG1 are shown as cyan spheres. Spacer domain SSEs within
the IP (intrinsic processivity subdomain) are shown in magenta;
ptDNA is indicated by orange (template) and brown (primer)
strands. The spacer domain is also shown as a transparent surface
representation in pale gray and the exo domain is shown in purple.
Brown spheres indicate the positions of the IP residues described in the
text.
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single alanine variants of ﬂy Pol g within this region of the
spacer: a W576A variant was nearly inactive, F578A
retained half of wild-type activity, G575A displayed
wild-type activity and all three variants showed substan-
tially reduced stimulation by mtSSB (38). The ﬂy G575/
W576/F578 residues correspond to residues G619/W620/
Y622 in human Pol g. In the human Pol g apoenzyme
structure, W620 is buried in the hydrophobic core of the
IP subdomain, whereas Y622 and G619 are located closer
to the surface (7). The combined biochemical data suggest
that residues closer to the distal surface of the IP domain
are not critical for catalytic function. Cluster 5 mutations
map to this surface, and therefore a catalytic defect per se
is not expected to be the cause of Alpers manifestation.
Rather, we propose that this region is involved in protein–
protein contacts, a likely partner being mtSSB as sug-
gested by the GWF ﬂy Pol g variants (38). Another can-
didate may be the mitochondrial replicative DNA helicase
Twinkle, but such an interaction has not been investigated
to date.
PROSPECTS
Toward a diagnostic tool to assess new human
mitochondrial disease mutations
We show that although the reported Alpers mutations
scatter across the entire POLG1 gene, they cluster to
distinct functional regions in the Pol g tertiary structure.
Table 1 summarizes the structure–function predictions for
each cluster and also displays the cluster combinations
that have been reported in compound heterozygous
patients with Alpers syndrome. These combinations do
not occur randomly; rather, multiple occurrences of
speciﬁc cluster combinations is evident whereas others
are absent, suggesting that the latter combinations are
not tolerated. Cluster 1 mutations locate in the pol
active site region and will invariably cause reduced pol
activity, potentially combined with reduced DNA
binding. Cluster 2 mutations locate in the upstream
DNA-binding channel, resulting in reduced DNA-
binding afﬁnity, but are too distant from the catalytic
site to affect directly pol activity to the extent of Cluster
1 mutations. Therefore, Cluster 2 mutations will be reces-
sive, whereas Cluster 1 mutations may be either dominant
or recessive, depending on the severity of the biochemical
defect. Cluster 3 mutations locate to the partitioning loop
or its environs, such as the orienter module, and we
predict that they will alter the balance of polymerase
and exonuclease activities of mutant Pol g. Cluster 4 mu-
tations locate on the surface of the exo domain along the
interface of the distal accessory subunit. These mutations
are predicted to reduce the stimulation affected by the
distal accessory subunit, which has been documented to
enhance pol rate and to reduce exo activity (45). Both
Clusters 3 and 4 mutations will likely cause increased mu-
tagenesis in vivo, a phenotype that has been observed in
yeast models to be associated with amino acid alterations
within these clusters (43). Cluster 5 mutations locate on
the distal surface of the intrinsic processivity (IP)
subdomain, removed from the pol active site,
DNA-binding channel and accessory subunit interface.
Their distant location and lack of biochemical defects
prompt us to speculate that this region is involved in
replisome contacts. This hypothesis, in particular, high-
lights the need for future experimentation on both the
physical and functional interactions among the key
proteins at the mtDNA replication fork.
POLG1 shows signiﬁcant polymorphic variation in the
human population, and a constant challenge in DNA
diagnosis is to distinguish pathogenic mutations from
Table 1. Structural and functional features of the ﬁve proposed Alpers Clusters
Cluster Structural location Predicted primary biochemical defect Predicted phenotype
(primary, secondary)
Causes Alpers when
found in trans
with Cluster
1 Pol active site and
environs
Pol activity Reduced pol rate
Reduced DNA-binding afﬁnity
Reduced processivity
2, 3 or 5
2 Upstream
DNA-binding
channel
DNA-binding afﬁnity Reduced DNA-binding afﬁnity
Reduced pol rate
Reduced processivity
1, 3, 4 or 5
3 Partitioning loop Partitioning of primer strand between
pol and exo active sites
Altered exo/ pol ratio
Altered substrate speciﬁcity
Altered error rate
Altered exo rate
Reduced DNA-binding afﬁnity
Reduced processivity
1, 2 or 5
4 Exo-IP interaction
(Stabilized by
distal Pol gB)
Stabilization of ternary complex Reduced pol rate enhancement by Pol cB
Decreased exo speciﬁcity
Increased error rate
Reduced processivity
2 or 5
5 Periphery of IP
domain
Protein–protein interactions Reduced SSB stimulation,
Other functions not studied to date
1, 2, 3 or 4
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neutral variants. We suggest that the remarkable cluster-
ing of Alpers mutations into speciﬁc functional regions
(Figure 1) enables the use of our Pol g:DNA model as a
diagnosis-supporting tool for evaluating pathogenic po-
tential of new sequence variants. For example, Q1102 is
located within the Cluster 1 region, and mutations affect-
ing this amino acid can be predicted to cause catalytic
defects. This prediction is consistent with biochemical
studies on the Q1102 counterpart in bacteriophage T7
Pol (Q615), which was shown to be essential for the
ﬁdelity of nucleotide incorporation and for ptDNA
binding (25). Functional predictions can be made in the
absence of biochemical data as well; for example, the tam9
mutant allele, carrying an E595V mutation in the catalytic
subunit of Pol g, causes mtDNA depletion in the ﬂy
(49,50). E595V corresponds to E641V in human Pol g,
which maps to Cluster 5 (Figure 6). Our model predicts
that the tam9-associated mtDNA depletion is caused by
deﬁcient replisome interactions. Consequently, we would
predict that both Q1102 and E641 are potential candidates
for causing recessive POLG syndrome with mtDNA
depletion.
Predicting the consequences of compound heterozygosity
via Alpers cluster analysis
Alpers syndrome is typically caused by compound hetero-
zygosity of two mutations occurring along the entire
length of the POLG1 gene. In contrast, homozygosity
for a single mutation often is associated with a
somewhat milder disorder (2,51). Utilizing the Human
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Figure 7. Combinations of mutations found in Alpers patients. Individual Alpers mutations are grouped by cluster as shown in Figure 1, and black
blocks represent Alpers manifesting combinations. The inset in the lower right presents a simpliﬁed version of the table by reducing the axes to the
ﬁve clusters only, where gray blocks represent cluster combinations that have not been found in Alpers patients. The tabulated data suggest that two
mutations from the same cluster do not typically manifest as early-onset Alpers disease. Furthermore, the data indicate that Cluster 4 (blue)
mutations manifest as Alpers disease only when in combination with Cluster 2 (yellow) or Cluster 5 (cyan) mutations. These trends support the
existence of unique functional relationships in Pol gA that are inherent to each cluster.
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DNA Polymerase g Database, we compiled data to show
all combinations of mutations that have been reported to
trigger Alpers disease (Figure 7). Alpers patients typically
do not show a combination of two mutations from the
same cluster. In addition, Cluster 4 mutations only
manifest as Alpers disease when combined with Clusters
2 or 5 mutations. These trends provide merit for our
structure-guided assignment of the mutations into the
ﬁve proposed clusters, and suggest unique functional
roles inherent to each. With the rapid development of
massive parallel sequencing methodologies, the number
of new Pol gA variants is likely to increase signiﬁcantly,
emphasizing the importance of bioinformatic tools to
evaluate the pathogenic role of identiﬁed variants.
Furthermore, the identiﬁcation of synergistic functional
relationships between the characterized clusters provides
novel insight into the mechanism of Alpers disease mani-
festation, and will serve as a framework for future struc-
ture–function studies of the mitochondrial DNA replicase.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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